Dr. Jessica Rose

Expert Witness (Researcher)

Appears in 12 sections across Day 2.

Day 2

• 4:48:24 Afternoon Session Opens: Dr. Jessica Rose Sworn In — Inquiry Proceedings
• 4:50:47 Rose: V-Safe FOIA Data and a ~26× Underreporting Factor — Pharmacovigilance Failures
• 4:53:15 Global AE Surge, Bradford Hill and the RotaShield Precedent — Pharmacovigilance Failures
• 4:57:54 U.S. CICP Rejection Rates and Canada’s Secret VISP Design — Compensation Program Failures
• 5:03:59 VISP Numbers, Appeals and PHAC’s Per-Dose Framing Trick — Compensation Program Failures
• 5:07:59 Q&A: Is the VAERS Underreporting Factor Closer to 30 or 100? — Pharmacovigilance Failures
• 5:10:00 Why Canadian Death-Reporting Rates Lag VAERS and Peer Systems — Pharmacovigilance Failures
• 5:13:29 Bungalow-to-Skyscraper: 2021 VAERS Anomaly vs Flu Controls — Pharmacovigilance Failures
• 5:22:22 Canadian Rows Inside Foreign VAERS and a Seven-Day Temporal Signal — Pharmacovigilance Failures
• 5:25:54 “Millions of Lives Saved” Rests on Fragile Modeling — Pharmacovigilance Failures
• 5:31:19 Rose Closes: Say No Next Time; Inquiry Thanks — Inquiry Proceedings
• 5:36:00 Q&A: What Legislation Would Force Clinicians to Report Injuries? — Pharmacovigilance Failures